Differential associations between smoking, e-cigarette use, and diabetes prevalence
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Cigarette smoking is a well-established risk factor for diabetes, but the relationship between e-cigarette use and diabetes remains uncertain. Evidence to date has been drawn almost entirely from North America and Asia, with little information from European populations. METHODS: We conducted a cross-sectional study of 17,854 adults aged 16 years and older from the 2017, 2018, 2019, and 2021 waves of the nationally representative Scottish Health Survey. Diabetes status was based on self-report of doctor-diagnosed diabetes. Participants were classified into six mutually exclusive categories of smoking and e-cigarette use: never users of either cigarettes or e-cigarettes, ex-smokers (former smokers who never used e-cigarettes), current exclusive cigarette smokers, current exclusive e-cigarette users, current dual users, and former e-cigarette users. Weighted prevalence estimates and survey-weighted binary logistic regression models were used to examine associations, adjusting for age group, sex, education, deprivation quintile, ethnicity, alcohol use, physical activity, and hypertension. RESULTS: Diabetes prevalence was highest among ex-smokers (11.3 %, 95 % CI: 10.1-12.5). Prevalence was 5.7 % (95 % CI: 5.2-6.2) among never users of either cigarettes or e-cigarettes, 6.2 % (95 % CI: 4.9-7.9) among current exclusive cigarette smokers, 4.9 % (95 % CI: 3.4-7.1) among current exclusive e-cigarette users, 8.3 % (95 % CI: 5.8-11.8) among current dual users, and 5.1 % (95 % CI: 4.1-6.3) among former e-cigarette users. In adjusted models, ex-smokers had 35 % higher odds of diabetes compared with never users of either cigarettes or e-cigarettes (OR = 1.35, 95 % CI = 1.14-1.60, p < 0.001), whereas current exclusive smokers (OR = 0.78, 95 % CI = 0.58-1.03, p = 0.084), current exclusive e-cigarette users (OR = 0.81, 95 % CI = 0.53-1.22, p = 0.309), current dual users (OR = 1.49, 95 % CI = 0.94-2.38, p = 0.091), and former e-cigarette users (OR = 1.00, 95 % CI = 0.78-1.29, p = 0.973) were not significantly different from never users. Sensitivity analyses restricting ex-smokers to those with ≥5 years since cessation and limiting the sample to adults aged ≥45 years reproduced the same pattern of results. CONCLUSIONS: In this nationally representative study of Scottish adults, excess diabetes prevalence was observed among ex-smokers, a pattern that may reflect both reverse causation if individuals quit smoking after diagnosis and the lasting metabolic effects of cumulative smoking exposure. Neither current nor former e-cigarette use was associated with diabetes, and the observed variation in prevalence appeared linked to smoking history rather than e-cigarette use. However, because vaping is relatively recent, further longitudinal research is needed to clarify any long-term risks.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology of Type 2 Diabetes – Global Burden of Disease and Forecasted Trends
Khan, M. A. B., Hashim, M. J., King, J. K., Govender, R. D., Mustafa, H., & Al Kaabi, J. (2019) · Journal of Epidemiology and Global Health · doi:10.2991/jegh.k.191028.001 · Cited by 3,130
Wang, X., & Cheng, Z. (2020) · CHEST · doi:10.1016/j.chest.2020.03.012 · Cited by 2,214
Hossain, M. J., Al‐Mamun, M., & Islam, M. R. (2024) · Health Science Reports · doi:10.1002/hsr2.2004 · Cited by 928
Pan, A., Wang, Y., Talaei, M., Hu, F. B., & Wu, T. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00316-2 · Cited by 551
Environmental Risk Factors for Developing Type 2 Diabetes Mellitus: A Systematic Review
Dendup, T., Feng, X., Clingan, S., & Astell-Burt, T. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15010078 · Cited by 440
Smoking and the risk of type 2 diabetes
Maddatu, J., Anderson-Baucum, E., & Evans-Molina, C. (2017) · Translational Research · doi:10.1016/j.trsl.2017.02.004 · Cited by 400
Validity and Reliability of Self-reported Diabetes in the Atherosclerosis Risk in Communities Study
Schneider, A. L. C., Pankow, J. S., Heiss, G., & Selvin, E. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kws156 · Cited by 238
Cardiovascular Effects of Switching From Tobacco Cigarettes to Electronic Cigarettes
George, J., Hussain, M., Vadiveloo, T., Ireland, S., Hopkinson, P., Struthers, A. D., Donnan, P. T., Khan, F., & Lang, C. C. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.09.067 · Cited by 223
Smoking and diabetes: dangerous liaisons and confusing relationships
Campagna, D., Alamo, A., Di Pino, A., Russo, C., Calogero, A. E., Purrello, F., & Polosa, R. (2019) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-019-0482-2 · Cited by 219
Self-citationNovel and Reversible Mechanisms of Smoking-Induced Insulin Resistance in Humans
Bergman, B. C., Perreault, L., Hunerdosse, D., Kerege, A., Playdon, M., Samek, A. M., & Eckel, R. H. (2012) · Diabetes · doi:10.2337/db12-0418 · Cited by 167
Chronic E-Cigarette Use Impairs Endothelial Function on the Physiological and Cellular Levels
Mohammadi, L., Han, D. D., Xu, F., Huang, A. S., Derakhshandeh, R., Rao, P., Whitlatch, A., Cheng, J., Keith, R. J., Hamburg, N. M., et al. (2022) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.121.317749 · Cited by 145
Tobacco smoking and vascular biology and function: evidence from human studies
Hahad, O., Kuntić, M., Kuntić, I., Daiber, A., & Münzel, T. F. (2023) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-023-02805-z · Cited by 112
Nicotine and Insulin Resistance: When the Smoke Clears
Bajaj, M. (2012) · Diabetes · doi:10.2337/db12-1100 · Cited by 107
Validation of self-reported diagnosis of diabetes in the 1946 British birth cohort
Pastorino, S., Richards, M., Hardy, R., Abington, J., Wills, A., Kuh, D., & Pierce, M. (2015) · Primary Care Diabetes · doi:10.1016/j.pcd.2014.05.003 · Cited by 92
Estimation of the global number of vapers: 82 million worldwide in 2021
Jerzyński, T., & Stimson, G. V. (2023) · Drugs Habits and Social Policy · doi:10.1108/dhs-07-2022-0028 · Cited by 86
Smoking and Diabetes: Does the Increased Risk Ever Go Away?
Luo, J., Rossouw, J., Tong, E., Giovino, G. A., Lee, C. C., Chen, C., Ockene, J. K., Qi, L., & Margolis, K. L. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kwt071 · Cited by 73
The Effects of Smoking on the Diagnostic Characteristics of Metabolic Syndrome: A Review
Behl, T. A., STAMFORD, B. A., & Moffatt, R. J. (2022) · American Journal of Lifestyle Medicine · doi:10.1177/15598276221111046 · Cited by 60
Tong, X., Chaudhry, Z. Z., Lee, C., Bone, R. N., Kanojia, S., Maddatu, J., Sohn, P., Weaver, S. A., Robertson, M. A., Petrache, I., et al. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.100975 · Cited by 53
Chronic Tobacco Exposure by Smoking Develops Insulin Resistance
Mukharjee, S., Bank, S., & Maiti, S. (2020) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530320666200217123901 · Cited by 49
Klonizakis, M., Gumber, A., McIntosh, E., & Brose, L. S. (2022) · BMC Medicine · doi:10.1186/s12916-022-02451-9 · Cited by 46
Prevalence of Popular Smoking Cessation Aids in England and Associations With Quit Success
Jackson, S. E., Brown, J., Buss, V. H., & Shahab, L. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.54962 · Cited by 45
Electronic Nicotine Delivery Systems and Cardiovascular/Cardiometabolic Health
Mears, M. J., Hookfin, H. L., Bandaru, P., Vidal, P., Stanford, K. I., & Wold, L. E. (2023) · Circulation Research · doi:10.1161/circresaha.123.321565 · Cited by 42
Electronic Cigarette Use and Metabolic Syndrome Development: A Critical Review
Górna, I., Napierała, M., & Florek, E. (2020) · Toxics · doi:10.3390/toxics8040105 · Cited by 36
Do E‐cigarettes induce weight changes and increase cardiometabolic risk? A signal for the future
Verhaegen, A. A., & Gaal, L. V. (2017) · Obesity Reviews · doi:10.1111/obr.12568 · Cited by 34
Atuegwu, N. C., Perez, M. F., Oncken, C. A., Mead, E. L., Maheshwari, N., & Mortensen, E. M. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.107692 · Cited by 33
Kim, T., Choi, H., Kang, J., & Kim, J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0237983 · Cited by 33
Zhang, Z., Jiao, Z., Blaha, M. J., Osei, A. D., Sidhaye, V. K., Ramanathan, M., & Biswal, S. S. (2022) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2021.12.009 · Cited by 30
Cai, J., & Bidulescu, A. (2023) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.110948 · Cited by 30
Orimoloye, O. A., Uddin, S. M. I., Chen, L., Osei, A. D., Mirbolouk, M., Malovichko, M. V., Sithu, I. D., Dzaye, O. D. A., Conklin, D. J., Srivastava, S., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0226744 · Cited by 29
Adebisi, Y. A., Lucero‐Prisno, D. E., & Ogunkola, I. O. (2025) · Internal and Emergency Medicine · doi:10.1007/s11739-025-03873-y · Cited by 21
Self-citationKlonizakis, M., Gumber, A., McIntosh, E., & Brose, L. S. (2021) · Biology · doi:10.3390/biology10111208 · Cited by 20
Dai, Y., Yang, W., Song, H., He, X., Guan, R., Wu, Z., Jiang, X., Li, M., Liu, P., & Chen, J. (2024) · Environment International · doi:10.1016/j.envint.2024.108521 · Cited by 19
Self-Rated Health by Time Since Smoking Cessation
Adebisi, Y. A., Alshahrani, N. Z., Ogunkola, I. O., & Jimoh, N. D. (2025) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2025.108040 · Cited by 17
Self-citationJeong, W., & Kim, S. J. (2024) · Epidemiology and Health · doi:10.4178/epih.e2024029 · Cited by 13
Diabetes cases in UK reach all time high, charity warns
Wise, J. (2023) · BMJ · doi:10.1136/bmj.p848 · Cited by 11
Adebisi, Y. A., Lungu, S., Curado, A., Oke, G., & Yach, D. (2025) · Ethics Medicine and Public Health · doi:10.1016/j.jemep.2025.101117 · Cited by 11
Self-citationConsideration of vaping products as an alternative to adult smoking: a narrative review
Foster, J. A. (2023) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-023-00571-w · Cited by 8
When meta-analysis misleads: the need for methodological integrity in e-cigarette research
Polosa, R., Geraci, G., & Adebisi, Y. A. (2025) · Internal and Emergency Medicine · doi:10.1007/s11739-025-04019-w · Cited by 8
Self-citationMoradpour, F., Piri, N., Dehghanbanadaki, H., Moradi, G., Fotouk-Kiai, M., & Moradi, Y. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01056-w · Cited by 7
Research works printed but not linked: 6
- Cao, 2024, An overview of environmental risk factors for type 2 diabetes research using network science tools, Digit Health, 10
- Collier, 2017, E-cigs have lower levels of harmful toxins, CMAJ (Can Med Assoc J), 189
- Neupane, 2024, Heterogeneous Association between E-Cigarette use and diabetes prevalence among U.S. adults, AJ Focus, 4
- Lim, 2024, Association between E-Cigarette smoking and insulin resistance using the triglyceride-glucose index in Korean adults: Korea National Health and Nutrition Examination Survey, Korean J Fam Med, 20
- Adebisi, 2025, 'E-cigarette smoking' is a misleading term: a critical review of its use in academic literature, Intern Emerg Med, 18
- Adebisi, 2025, Who does not want to quit? Determinants of no intention to stop smoking in a population-based sample of current smokers, Intern Emerg Med, 4
Metadata
- Authors
- Adebisi, Y. A., Ngoma, C., Campagna, D., Ceriello, A., Alshahrani, N. Z., Misra, A., Basit, A., Russo, C., Battelino, T., Somasundaram, N., Jalaludin, M. Y., Le Dinh, P., Saisho, Y., Walicka, M., Tomaselli, V., Cantone, G., Moser, O., & Polosa, R.
- Venue
- Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Publisher
- Elsevier BV
- Published
- 2025-10
- Volume
- 19
- Issue
- 10
- Pages
- 103331
- ISSN
- 1871-4021
- Cited by
- 8
- References
- 39
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 51 d)
- Funders
- University of Glasgow
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.